Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain Metastasis

About 20–40% of cancer patients develop brain metastases, causing significant morbidity and mortality. Stereotactic radiation treatment is an established option that delivers high dose radiation to the target while sparing the surrounding normal tissue. However, up to 20% of metastatic brain tumours...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Elham, Soliman, Hany, Ruschin, Mark, Sahgal, Arjun, Myrehaug, Sten, Tseng, Chia-Lin, Czarnota, Gregory J., Jabehdar-Maralani, Pejman, Chugh, Brige, Lau, Angus, Stanisz, Greg J., Sadeghi-Naini, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934477/
https://www.ncbi.nlm.nih.gov/pubmed/31882597
http://dx.doi.org/10.1038/s41598-019-56185-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934477/
https://www.ncbi.nlm.nih.gov/pubmed/31882597
http://dx.doi.org/10.1038/s41598-019-56185-5

Ejemplares similares